Melotop

Meloxicam, the active ingredient in Melotop, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients. It belongs to the class of cyclooxygenase‑2 preferential inhibitors, offering anti‑inflammatory and analgesic benefits.

GNH USA supplies Melotop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Meloxicam is used to treat inflammatory joint disorders and acute pain conditions. - Osteoarthritis: reduces joint pain, stiffness and inflammation, improving mobility. - Rheumatoid arthritis: alleviates chronic joint inflammation and pain, helping preserve function. - Ankylosing spondylitis: diminishes spinal inflammation and associated discomfort. - Acute pain: provides short‑term relief of moderate to severe pain from various causes.

Meloxicam may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, abdominal pain or mild indigestion. - Headache: mild to moderate intensity, often transient. - Dizziness or vertigo: sensation of light‑headedness or balance disturbance. Serious or Rare Side Effects: - Peptic ulcer or gastrointestinal bleeding: may present as black stools or vomiting blood. - Severe hepatic injury: jaundice, dark urine, markedly elevated liver enzymes. - Anaphylaxis or severe hypersensitivity reactions: swelling of face, throat, difficulty breathing.

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risks. - Assess renal function: avoid use in patients with severe renal impairment. - Monitor hepatic enzymes: use cautiously in those with liver disease. - Evaluate cardiovascular risk: NSAIDs may increase risk of thrombotic events. - Use lowest effective dose: limit duration to the shortest period necessary. - Avoid in patients with known hypersensitivity to NSAIDs. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Meloxicam can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - High‑dose aspirin: heightened risk of ulceration and bleeding. Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients. - Diuretics: potential for decreased kidney perfusion. - Lithium: NSAIDs can raise lithium serum levels, risking toxicity.